Data from Intratumoral <i>De Novo</i> Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors Article Swipe
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/0008-5472.c.6502257.v1
Relapse of castration-resistant prostate cancer (CRPC) that occurs after androgen deprivation therapy of primary prostate cancer can be mediated by reactivation of the androgen receptor (AR). One important mechanism mediating this AR reactivation is intratumoral conversion of the weak adrenal androgens DHEA and androstenedione into the AR ligands testosterone and dihydrotestosterone. DHEA and androstenedione are synthesized by the adrenals through the sequential actions of the cytochrome P450 enzymes CYP11A1 and CYP17A1, so that CYP17A1 inhibitors such as abiraterone are effective therapies for CRPC. However, the significance of intratumoral CYP17A1 and de novo androgen synthesis from cholesterol in CRPC, and the mechanisms contributing to CYP17A1 inhibitor resistance/relapse, remain to be determined. We report that AR activity in castration-resistant VCaP tumor xenografts can be restored through CYP17A1-dependent de novo androgen synthesis, and that abiraterone treatment of these xenografts imposes selective pressure for increased intratumoral expression of CYP17A1, thereby generating a mechanism for development of resistance to CYP17A1 inhibitors. Supporting the clinical relevance of this mechanism, we found that intratumoral expression of CYP17A1 was markedly increased in tumor biopsies from CRPC patients after CYP17A1 inhibitor therapy. We further show that CRPC cells expressing a progesterone responsive T877A mutant AR are not CYP17A1 dependent, but that AR activity in these cells is still steroid dependent and mediated by upstream CYP11A1-dependent intraturmoral pregnenolone/progesterone synthesis. Together, our results indicate that CRPCs resistant to CYP17A1 inhibition may remain steroid dependent and therefore responsive to therapies that can further suppress de novo intratumoral steroid synthesis. Cancer Res; 71(20); 6503–13. ©2011 AACR.
Related Topics
- Type
- preprint
- Language
- en
- Landing Page
- https://doi.org/10.1158/0008-5472.c.6502257.v1
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4392685848
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4392685848Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/0008-5472.c.6502257.v1Digital Object Identifier
- Title
-
Data from Intratumoral <i>De Novo</i> Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 InhibitorsWork title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-03-30Full publication date if available
- Authors
-
Changmeng Cai, Sen Chen, Patrick Ng, Glenn J. Bubley, Peter S. Nelson, Elahe A. Mostaghel, Brett T. Marck, Alvin M. Matsumoto, Nicholas I. Simon, Hongyun Wang, Shaoyong Chen, Steven P. BalkList of authors in order
- Landing page
-
https://doi.org/10.1158/0008-5472.c.6502257.v1Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1158/0008-5472.c.6502257.v1Direct OA link when available
- Concepts
-
Prostate cancer, CYP17A1, Downregulation and upregulation, Androgen receptor, Castration, Androgen deprivation therapy, Steroid, Prostate, Androgen, Cancer research, Medicine, Endocrinology, Internal medicine, Cancer, Chemistry, Hormone, Gene, BiochemistryTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4392685848 |
|---|---|
| doi | https://doi.org/10.1158/0008-5472.c.6502257.v1 |
| ids.doi | https://doi.org/10.1158/0008-5472.c.6502257.v1 |
| ids.openalex | https://openalex.org/W4392685848 |
| fwci | |
| type | preprint |
| title | Data from Intratumoral <i>De Novo</i> Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10543 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9994000196456909 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2740 |
| topics[0].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[0].display_name | Prostate Cancer Treatment and Research |
| topics[1].id | https://openalex.org/T10756 |
| topics[1].field.id | https://openalex.org/fields/13 |
| topics[1].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[1].score | 0.9979000091552734 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1311 |
| topics[1].subfield.display_name | Genetics |
| topics[1].display_name | Estrogen and related hormone effects |
| topics[2].id | https://openalex.org/T11146 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9976000189781189 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2712 |
| topics[2].subfield.display_name | Endocrinology, Diabetes and Metabolism |
| topics[2].display_name | Hormonal and reproductive studies |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2780192828 |
| concepts[0].level | 3 |
| concepts[0].score | 0.7654682397842407 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q181257 |
| concepts[0].display_name | Prostate cancer |
| concepts[1].id | https://openalex.org/C142716871 |
| concepts[1].level | 3 |
| concepts[1].score | 0.7559899091720581 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q408305 |
| concepts[1].display_name | CYP17A1 |
| concepts[2].id | https://openalex.org/C127561419 |
| concepts[2].level | 3 |
| concepts[2].score | 0.7377591729164124 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q224527 |
| concepts[2].display_name | Downregulation and upregulation |
| concepts[3].id | https://openalex.org/C61367390 |
| concepts[3].level | 4 |
| concepts[3].score | 0.720366358757019 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q416601 |
| concepts[3].display_name | Androgen receptor |
| concepts[4].id | https://openalex.org/C2779256933 |
| concepts[4].level | 3 |
| concepts[4].score | 0.5872666835784912 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q58929 |
| concepts[4].display_name | Castration |
| concepts[5].id | https://openalex.org/C2777899217 |
| concepts[5].level | 4 |
| concepts[5].score | 0.5822373032569885 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q4759439 |
| concepts[5].display_name | Androgen deprivation therapy |
| concepts[6].id | https://openalex.org/C2780902042 |
| concepts[6].level | 3 |
| concepts[6].score | 0.5593283772468567 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q177911 |
| concepts[6].display_name | Steroid |
| concepts[7].id | https://openalex.org/C2776235491 |
| concepts[7].level | 3 |
| concepts[7].score | 0.5304866433143616 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q9625 |
| concepts[7].display_name | Prostate |
| concepts[8].id | https://openalex.org/C2777911890 |
| concepts[8].level | 3 |
| concepts[8].score | 0.5198457837104797 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q62614 |
| concepts[8].display_name | Androgen |
| concepts[9].id | https://openalex.org/C502942594 |
| concepts[9].level | 1 |
| concepts[9].score | 0.4532639682292938 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[9].display_name | Cancer research |
| concepts[10].id | https://openalex.org/C71924100 |
| concepts[10].level | 0 |
| concepts[10].score | 0.44914039969444275 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[10].display_name | Medicine |
| concepts[11].id | https://openalex.org/C134018914 |
| concepts[11].level | 1 |
| concepts[11].score | 0.44403427839279175 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q162606 |
| concepts[11].display_name | Endocrinology |
| concepts[12].id | https://openalex.org/C126322002 |
| concepts[12].level | 1 |
| concepts[12].score | 0.44377627968788147 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[12].display_name | Internal medicine |
| concepts[13].id | https://openalex.org/C121608353 |
| concepts[13].level | 2 |
| concepts[13].score | 0.4228109121322632 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[13].display_name | Cancer |
| concepts[14].id | https://openalex.org/C185592680 |
| concepts[14].level | 0 |
| concepts[14].score | 0.27004480361938477 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[14].display_name | Chemistry |
| concepts[15].id | https://openalex.org/C71315377 |
| concepts[15].level | 2 |
| concepts[15].score | 0.16713061928749084 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q11364 |
| concepts[15].display_name | Hormone |
| concepts[16].id | https://openalex.org/C104317684 |
| concepts[16].level | 2 |
| concepts[16].score | 0.0744599997997284 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q7187 |
| concepts[16].display_name | Gene |
| concepts[17].id | https://openalex.org/C55493867 |
| concepts[17].level | 1 |
| concepts[17].score | 0.05566447973251343 |
| concepts[17].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[17].display_name | Biochemistry |
| keywords[0].id | https://openalex.org/keywords/prostate-cancer |
| keywords[0].score | 0.7654682397842407 |
| keywords[0].display_name | Prostate cancer |
| keywords[1].id | https://openalex.org/keywords/cyp17a1 |
| keywords[1].score | 0.7559899091720581 |
| keywords[1].display_name | CYP17A1 |
| keywords[2].id | https://openalex.org/keywords/downregulation-and-upregulation |
| keywords[2].score | 0.7377591729164124 |
| keywords[2].display_name | Downregulation and upregulation |
| keywords[3].id | https://openalex.org/keywords/androgen-receptor |
| keywords[3].score | 0.720366358757019 |
| keywords[3].display_name | Androgen receptor |
| keywords[4].id | https://openalex.org/keywords/castration |
| keywords[4].score | 0.5872666835784912 |
| keywords[4].display_name | Castration |
| keywords[5].id | https://openalex.org/keywords/androgen-deprivation-therapy |
| keywords[5].score | 0.5822373032569885 |
| keywords[5].display_name | Androgen deprivation therapy |
| keywords[6].id | https://openalex.org/keywords/steroid |
| keywords[6].score | 0.5593283772468567 |
| keywords[6].display_name | Steroid |
| keywords[7].id | https://openalex.org/keywords/prostate |
| keywords[7].score | 0.5304866433143616 |
| keywords[7].display_name | Prostate |
| keywords[8].id | https://openalex.org/keywords/androgen |
| keywords[8].score | 0.5198457837104797 |
| keywords[8].display_name | Androgen |
| keywords[9].id | https://openalex.org/keywords/cancer-research |
| keywords[9].score | 0.4532639682292938 |
| keywords[9].display_name | Cancer research |
| keywords[10].id | https://openalex.org/keywords/medicine |
| keywords[10].score | 0.44914039969444275 |
| keywords[10].display_name | Medicine |
| keywords[11].id | https://openalex.org/keywords/endocrinology |
| keywords[11].score | 0.44403427839279175 |
| keywords[11].display_name | Endocrinology |
| keywords[12].id | https://openalex.org/keywords/internal-medicine |
| keywords[12].score | 0.44377627968788147 |
| keywords[12].display_name | Internal medicine |
| keywords[13].id | https://openalex.org/keywords/cancer |
| keywords[13].score | 0.4228109121322632 |
| keywords[13].display_name | Cancer |
| keywords[14].id | https://openalex.org/keywords/chemistry |
| keywords[14].score | 0.27004480361938477 |
| keywords[14].display_name | Chemistry |
| keywords[15].id | https://openalex.org/keywords/hormone |
| keywords[15].score | 0.16713061928749084 |
| keywords[15].display_name | Hormone |
| keywords[16].id | https://openalex.org/keywords/gene |
| keywords[16].score | 0.0744599997997284 |
| keywords[16].display_name | Gene |
| keywords[17].id | https://openalex.org/keywords/biochemistry |
| keywords[17].score | 0.05566447973251343 |
| keywords[17].display_name | Biochemistry |
| language | en |
| locations[0].id | doi:10.1158/0008-5472.c.6502257.v1 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1158/0008-5472.c.6502257.v1 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5050848129 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-8701-2586 |
| authorships[0].author.display_name | Changmeng Cai |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Changmeng Cai |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5100658278 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-5872-2597 |
| authorships[1].author.display_name | Sen Chen |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Sen Chen |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5102761306 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-8208-652X |
| authorships[2].author.display_name | Patrick Ng |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Patrick Ng |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5043769628 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-3062-643X |
| authorships[3].author.display_name | Glenn J. Bubley |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Glenn J. Bubley |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5067800417 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-5451-5726 |
| authorships[4].author.display_name | Peter S. Nelson |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Peter S. Nelson |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5071509387 |
| authorships[5].author.orcid | https://orcid.org/0000-0001-8169-8743 |
| authorships[5].author.display_name | Elahe A. Mostaghel |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Elahe A. Mostaghel |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5028428149 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Brett T. Marck |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Brett Marck |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5052592209 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-6506-8650 |
| authorships[7].author.display_name | Alvin M. Matsumoto |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Alvin M. Matsumoto |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5033450748 |
| authorships[8].author.orcid | https://orcid.org/0000-0003-1259-9201 |
| authorships[8].author.display_name | Nicholas I. Simon |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Nicholas I. Simon |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5101635645 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | Hongyun Wang |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Hongyun Wang |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5066896225 |
| authorships[10].author.orcid | https://orcid.org/0000-0003-0809-8383 |
| authorships[10].author.display_name | Shaoyong Chen |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Shaoyong Chen |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A5087350413 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-4546-7371 |
| authorships[11].author.display_name | Steven P. Balk |
| authorships[11].author_position | last |
| authorships[11].raw_author_name | Steven P. Balk |
| authorships[11].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1158/0008-5472.c.6502257.v1 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Data from Intratumoral <i>De Novo</i> Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10543 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9994000196456909 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2740 |
| primary_topic.subfield.display_name | Pulmonary and Respiratory Medicine |
| primary_topic.display_name | Prostate Cancer Treatment and Research |
| related_works | https://openalex.org/W2142312240, https://openalex.org/W178050054, https://openalex.org/W4380904910, https://openalex.org/W2769289310, https://openalex.org/W2011309992, https://openalex.org/W2993729724, https://openalex.org/W2265514567, https://openalex.org/W1989552101, https://openalex.org/W2315576954, https://openalex.org/W2139711232 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1158/0008-5472.c.6502257.v1 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1158/0008-5472.c.6502257.v1 |
| primary_location.id | doi:10.1158/0008-5472.c.6502257.v1 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1158/0008-5472.c.6502257.v1 |
| publication_date | 2023-03-30 |
| publication_year | 2023 |
| referenced_works_count | 0 |
| abstract_inverted_index.a | 147, 190 |
| abstract_inverted_index.AR | 31, 46, 113, 195, 202 |
| abstract_inverted_index.We | 110, 183 |
| abstract_inverted_index.as | 76 |
| abstract_inverted_index.be | 17, 108, 121 |
| abstract_inverted_index.by | 19, 56, 213 |
| abstract_inverted_index.in | 96, 115, 173, 204 |
| abstract_inverted_index.is | 33, 207 |
| abstract_inverted_index.of | 1, 12, 21, 36, 63, 86, 133, 143, 151, 160, 168 |
| abstract_inverted_index.so | 71 |
| abstract_inverted_index.to | 102, 107, 153, 226, 236 |
| abstract_inverted_index.we | 163 |
| abstract_inverted_index.One | 26 |
| abstract_inverted_index.and | 42, 49, 52, 69, 89, 98, 129, 211, 233 |
| abstract_inverted_index.are | 54, 78, 196 |
| abstract_inverted_index.but | 200 |
| abstract_inverted_index.can | 16, 120, 239 |
| abstract_inverted_index.for | 81, 139, 149 |
| abstract_inverted_index.may | 229 |
| abstract_inverted_index.not | 197 |
| abstract_inverted_index.our | 220 |
| abstract_inverted_index.the | 22, 37, 45, 57, 60, 64, 84, 99, 157 |
| abstract_inverted_index.was | 170 |
| abstract_inverted_index.CRPC | 177, 187 |
| abstract_inverted_index.DHEA | 41, 51 |
| abstract_inverted_index.P450 | 66 |
| abstract_inverted_index.Res; | 248 |
| abstract_inverted_index.VCaP | 117 |
| abstract_inverted_index.from | 94, 176 |
| abstract_inverted_index.into | 44 |
| abstract_inverted_index.show | 185 |
| abstract_inverted_index.such | 75 |
| abstract_inverted_index.that | 6, 72, 112, 130, 165, 186, 201, 223, 238 |
| abstract_inverted_index.this | 30, 161 |
| abstract_inverted_index.weak | 38 |
| abstract_inverted_index.(AR). | 25 |
| abstract_inverted_index.CRPC, | 97 |
| abstract_inverted_index.CRPC. | 82 |
| abstract_inverted_index.CRPCs | 224 |
| abstract_inverted_index.T877A | 193 |
| abstract_inverted_index.after | 8, 179 |
| abstract_inverted_index.cells | 188, 206 |
| abstract_inverted_index.found | 164 |
| abstract_inverted_index.still | 208 |
| abstract_inverted_index.these | 134, 205 |
| abstract_inverted_index.tumor | 118, 174 |
| abstract_inverted_index.(CRPC) | 5 |
| abstract_inverted_index.cancer | 4, 15 |
| abstract_inverted_index.mutant | 194 |
| abstract_inverted_index.occurs | 7 |
| abstract_inverted_index.remain | 106, 230 |
| abstract_inverted_index.report | 111 |
| abstract_inverted_index.©2011 | 251 |
| abstract_inverted_index.71(20); | 249 |
| abstract_inverted_index.CYP11A1 | 68 |
| abstract_inverted_index.CYP17A1 | 73, 88, 103, 154, 169, 180, 198, 227 |
| abstract_inverted_index.actions | 62 |
| abstract_inverted_index.adrenal | 39 |
| abstract_inverted_index.enzymes | 67 |
| abstract_inverted_index.further | 184, 240 |
| abstract_inverted_index.imposes | 136 |
| abstract_inverted_index.ligands | 47 |
| abstract_inverted_index.primary | 13 |
| abstract_inverted_index.results | 221 |
| abstract_inverted_index.steroid | 209, 231, 245 |
| abstract_inverted_index.therapy | 11 |
| abstract_inverted_index.thereby | 145 |
| abstract_inverted_index.through | 59, 123 |
| abstract_inverted_index.CYP17A1, | 70, 144 |
| abstract_inverted_index.However, | 83 |
| abstract_inverted_index.activity | 114, 203 |
| abstract_inverted_index.adrenals | 58 |
| abstract_inverted_index.androgen | 9, 23, 92, 127 |
| abstract_inverted_index.biopsies | 175 |
| abstract_inverted_index.clinical | 158 |
| abstract_inverted_index.indicate | 222 |
| abstract_inverted_index.markedly | 171 |
| abstract_inverted_index.mediated | 18, 212 |
| abstract_inverted_index.patients | 178 |
| abstract_inverted_index.pressure | 138 |
| abstract_inverted_index.prostate | 3, 14 |
| abstract_inverted_index.receptor | 24 |
| abstract_inverted_index.restored | 122 |
| abstract_inverted_index.suppress | 241 |
| abstract_inverted_index.therapy. | 182 |
| abstract_inverted_index.upstream | 214 |
| abstract_inverted_index.Together, | 219 |
| abstract_inverted_index.androgens | 40 |
| abstract_inverted_index.dependent | 210, 232 |
| abstract_inverted_index.effective | 79 |
| abstract_inverted_index.important | 27 |
| abstract_inverted_index.increased | 140, 172 |
| abstract_inverted_index.inhibitor | 104, 181 |
| abstract_inverted_index.mechanism | 28, 148 |
| abstract_inverted_index.mediating | 29 |
| abstract_inverted_index.relevance | 159 |
| abstract_inverted_index.resistant | 225 |
| abstract_inverted_index.selective | 137 |
| abstract_inverted_index.synthesis | 93 |
| abstract_inverted_index.therapies | 80, 237 |
| abstract_inverted_index.therefore | 234 |
| abstract_inverted_index.treatment | 132 |
| abstract_inverted_index.6503–13. | 250 |
| abstract_inverted_index.Supporting | 156 |
| abstract_inverted_index.conversion | 35 |
| abstract_inverted_index.cytochrome | 65 |
| abstract_inverted_index.dependent, | 199 |
| abstract_inverted_index.expressing | 189 |
| abstract_inverted_index.expression | 142, 167 |
| abstract_inverted_index.generating | 146 |
| abstract_inverted_index.inhibition | 228 |
| abstract_inverted_index.inhibitors | 74 |
| abstract_inverted_index.mechanism, | 162 |
| abstract_inverted_index.mechanisms | 100 |
| abstract_inverted_index.resistance | 152 |
| abstract_inverted_index.responsive | 192, 235 |
| abstract_inverted_index.sequential | 61 |
| abstract_inverted_index.synthesis, | 128 |
| abstract_inverted_index.synthesis. | 218, 246 |
| abstract_inverted_index.xenografts | 119, 135 |
| abstract_inverted_index.<i>de | 90, 125, 242 |
| abstract_inverted_index.abiraterone | 77, 131 |
| abstract_inverted_index.cholesterol | 95 |
| abstract_inverted_index.deprivation | 10 |
| abstract_inverted_index.determined. | 109 |
| abstract_inverted_index.development | 150 |
| abstract_inverted_index.inhibitors. | 155 |
| abstract_inverted_index.synthesized | 55 |
| abstract_inverted_index.contributing | 101 |
| abstract_inverted_index.intratumoral | 34, 87, 141, 166, 244 |
| abstract_inverted_index.progesterone | 191 |
| abstract_inverted_index.reactivation | 20, 32 |
| abstract_inverted_index.significance | 85 |
| abstract_inverted_index.testosterone | 48 |
| abstract_inverted_index.intraturmoral | 216 |
| abstract_inverted_index.novo</i> | 91, 126, 243 |
| abstract_inverted_index.<i>Cancer | 247 |
| abstract_inverted_index.androstenedione | 43, 53 |
| abstract_inverted_index.CYP11A1-dependent | 215 |
| abstract_inverted_index.CYP17A1-dependent | 124 |
| abstract_inverted_index.resistance/relapse, | 105 |
| abstract_inverted_index.castration-resistant | 2, 116 |
| abstract_inverted_index.dihydrotestosterone. | 50 |
| abstract_inverted_index.pregnenolone/progesterone | 217 |
| abstract_inverted_index.<div>Abstract<p>Relapse | 0 |
| abstract_inverted_index.AACR</i>.</p></div> | 252 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 12 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.5899999737739563 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.48628001 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |